Biomarker Detection Using Omics and Clinical Translation

Wednesday, November 13 • 10:30 a.m. – 12:00 p.m.

Biomarkers are critical to enabling precision medicine for patients. However, multiple challenges exist, including patient/sample heterogeneity, integration of multiple omics data types and clinical translation. This session will discuss these aspects of biomarker detection and the considerations for successful translation to the clinic.

Session Chair:

Anupama Reddy, Ph.D. (Vindhya Data Science)

Speakers:

NR Nirmala, M.Sc., Ph.D. (Vindhya Data Science)
Topic: From Predictive Model to Clinic: Facilitating Patient Selection in Biomarker-Driven Trials

Michael Seiler, Ph.D. (Remix Therapeutics)
Topic: REM-422, a Small Molecule that Reprograms RNA Processing to Target MYB-Driven Hematological and Solid Cancer

Rens Janssens, M.S. (Novartis Oncology)
Topic: Biologically Relevant Integration of Transcriptomics Profiles from Cancer Cell Lines, Patient-Derived Xenografts and Clinical Tumors Using Deep Learning